ST-elevation myocardial infarction (STEMI) is one of the leading causes of death and hospitalization worldwide. Hyperglycemia (HG) has been shown to adversely affect STEMI clinical outcomes, leading to higher mortality and severe complications . The aim of our study was to investigate the impact of HG at hospital admission on the risk of restenosis after primary percutaneous coronary intervention (PCI) for STEMI, comparing normoglycemic subjects (NG group), patients without diabetes mellitus (DM) but with HG (HG-non-DM group), and patients with both HG and DM (HG-DM group).
Hyperglycemia Drives Stent Restenosis in STEMI Patients / Mone, P; Gambardella, J; Minicucci, F; Lombardi, A; Mauro, C; Santulli, G. - In: DIABETES CARE. - ISSN 0149-5992. - 44:11(2021), pp. 192-193. [10.2337/dc21-0939]
Hyperglycemia Drives Stent Restenosis in STEMI Patients
Lombardi AData Curation
;
2021
Abstract
ST-elevation myocardial infarction (STEMI) is one of the leading causes of death and hospitalization worldwide. Hyperglycemia (HG) has been shown to adversely affect STEMI clinical outcomes, leading to higher mortality and severe complications . The aim of our study was to investigate the impact of HG at hospital admission on the risk of restenosis after primary percutaneous coronary intervention (PCI) for STEMI, comparing normoglycemic subjects (NG group), patients without diabetes mellitus (DM) but with HG (HG-non-DM group), and patients with both HG and DM (HG-DM group).| File | Dimensione | Formato | |
|---|---|---|---|
|
Mone_Hyperglycemia_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
826.58 kB
Formato
Adobe PDF
|
826.58 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
